Hospitals > Research and education
Training and research
Approximately one in every five adults has sleep-disordered breathing (SDB).1
An expanding body of scientific evidence clearly indicates that this growing condition is having a profound negative impact on public health.
Through our strong, proactive partnership with the global medical community, ResMed is committed to:
- increasing awareness of the dangers of untreated SDB
- supporting ongoing research into the correlation of SDB with other health risks
- finding effective clinical solutions to improve the health and lives of SDB patients.
We believe that industry and medical science must work together to enhance medicine and patient therapy. Our acclaimed sleep program was developed in support of this philosophy
ResMed Academy Online
The ResMed Academy Online is designed to provide you with easy access to a variety of learning resources at no cost.
We believe that industry and medical science must work together to enhance medicine and patient therapy. Our acclaimed sleep program was developed in support of this philosophy.
Read a selection of recently published clinical articles about a range of topics.
ResMed Founder and Chairman, Dr. Peter Farrell, identifies key research findings that are shaping the field of sleep medicine today.
Learn more about the differences between fixed pressure and auto-adjusting therapy devices.
Read about research on traffic accidents in relation to sleep and respiratory care.
Sleep-disordered breathing and positive airway pressure
Read more research on the topics of sleep-disordered breathing (SDB) and positive airway pressure (PAP).
Diabetes and sleep apnea
Explore research about diabetes in relation to sleep and respiratory care.
Sleep therapy compliance
Read about research on compliance in relation to sleep apnea treatment.
Obesity and sleep apnea
Read about obesity research in relation to sleep-disordered breathing and respiratory care.
The HOT-HMV study
The HOT-HMV trial shows that home mechanical ventilation (HMV) combined with home oxygen therapy (HOT) significantly reduces the risk of hospital readmission or death in severe COPD patients after an acute COPD exacerbation requiring NIV.